The Duke University School of Medicine has a strong tradition of genomic discoveries. The Precision Genomics Collaboratory brings together all of the units in Duke focused on genomics research to create a multi-disciplinary community able to tackle challenges in the ever-evolving genomics landscape.
Featured Publication
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
Senthil Selvaraj, Robert McGarrah, Olga Ilkayeva, Chris Newgard, Svati Shah and colleagues explored whether metabolic effects of sodium-glucose cotransporter-2 inhibitors vary across the left ventricular ejection fraction spectrum and their relationship with cardiometabolic end points in two randomized trials of dapagliflozin in heart failure.
Funding Opportunity
Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
The National Human Genome Research Institute (NHGRI) is issuing this Notice of Special Interest (NOSI) to encourage applications focused on developing novel laboratory-focused tools and technologies that enable new lines of scientific inquiry and advance research or clinical applications in human genomics.
Our Community
Duke Molecular Physiology Institute
Duke Center for Advanced Genomic Technologies
Duke Center for Genomics and Computational Biology
Duke Center for Statistical Genetics and Genomics
Center for Precision Health
Duke Microbiome Center
Division of Integrative Genomics in the Department of Biostatistics & Bioinformatics
Division of Human Genetics in the Department of Molecular Genetics and Microbiology
Division of Medical Genetics in the Department of Pediatrics
Adult Cardiovascular Genetics Clinic
Clinical Cancer Genetics
